Biomason’s Microbe-Grown ‘Biocement’ Emerges as Low-Carbon Challenger to World’s Most Polluting Building Material

Biomason, a biotechnology firm operating out of Research Triangle Park, North Carolina, and Copenhagen, Denmark, is commercializing a cement alternative grown with living microorganisms rather than produced in fossil-fuel-fired kilns. The process, which the company calls ‘biocement,’ aims to displace a portion of the roughly 30 billion tons of conventional concrete poured globally each year — an industry responsible for more carbon dioxide emissions than the entire global aviation and maritime shipping sectors combined.

Concrete is the most-used manufactured material on Earth, second only to water in total human consumption. Its environmental cost, however, has drawn increasing scrutiny from climate scientists and policymakers. The chemical conversion of limestone into clinker — the key binding ingredient in Portland cement — releases carbon dioxide twice over: once from the fossil fuels burned to heat kilns to temperatures exceeding 1,400 degrees Celsius, and again when the limestone itself chemically decomposes. Together, those two steps account for roughly half of all cement-related emissions each. If the global cement industry were a country, it would rank as the world’s third-largest emitter of carbon dioxide, trailing only China and the United States.

Biomason’s approach turns that chemistry on its head. Rather than using heat to forge a binder, the company seeds aggregate materials such as sand with a strain of bacteria that, when fed a calcium-rich solution, precipitate calcium carbonate crystals — effectively the same mineral that forms coral reefs and seashells. Within 72 hours, the microbes cement loose grains into a hardened material that company testing indicates meets or exceeds the compressive strength requirements of standard masonry. Because the process occurs at ambient temperature and relies on biologically driven mineralization, Biomason states that its tiles carry a carbon footprint up to 95% lower than traditional concrete products of equivalent durability.

Scaling biocement remains the central challenge. Current applications have focused largely on precast tiles and cladding rather than poured structural concrete, which still represents the vast majority of global demand. Biomason has announced partnerships and licensing agreements intended to extend the technology into standardized production lines overseas, and it has attracted investment from venture funds focused on climate technology and the built environment. Whether biocement can move from boutique architectural surfaces into bridges, highways, and high-rise foundations will determine the extent of its climate impact over the coming decade, as governments begin rolling out procurement rules — including Buy Clean policies in several U.S. states and the European Union’s Carbon Border Adjustment Mechanism — that favor low-embodied-carbon materials.